Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
The U.S. Food and Drug Administration recalls nearly 90k bottles of children's ibuprofen medication nationwide.
The U.S. Food and Drug Administration recently announced the recall of nearly 90k bottles of children’s ibuprofen medication distributed nationwide, due to consumer complaints of foreign objects in the liquid. According to the recall report issued by the FDA, this batch of medication was manufactured in India by the international pharmaceutical company Progress Pharmaceuticals, headquartered in Bangalore, India. The brand is “Tarro Pharmaceuticals Children’s Ibuprofen Oral Suspension,” with a specification of 100 milligrams of ibuprofen active ingredient per 5 milliliters, and a bottle capacity of 120 milliliters. The recall involves a total of 89,592 bottles, with an expiration date of January 31, 2027. The report states that the reason for the recall is consumer complaints of foreign objects such as “gel-like substances” and “black particles” in the liquid. (Cailian Press)